longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Mindray

300760

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 24.70, below the reasonable range, cheaper than 82.02% of the time in the past 5 years, and the industry ranks 14/65, the industry Median 27.22.

24.7xP/E
¥160.30Stock price
¥6.49Earnings per share
24.7xP/E
Stock price¥160.30Earnings per share¥6.49

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
30.34x
Typical range
24.89x–41.11x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 27.22x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 27.22x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
300760SZMindray
24.70x1.70%¥194.25B
002223SZYUYUE MEDICAL
23.29x0.70%¥26.13B
300003SZLepu Medical
27.22x16.83%¥20.98B
002901SZDouble Medical
22.88x13.61%¥16.22B
603014SHWeigao Blood Purification
25.92x2.19%¥12.75B
300529SZJAFRON
22.60x18.12%¥11.87B
600587SHSHINVA
17.42x--¥7.42B
300206SZEdan
18.00x--¥6.35B
301367SZBMC
24.21x27.60%¥5.35B
688236SHChunli Medical
18.47x0.00%¥5.14B
688581SHAGS
21.56x79.57%¥4.61B
300326SZKinetic Medical
19.22x--¥4.32B
688410SHSWS Medical
22.39x45.87%¥4.15B
688580SHVISHEE
23.29x20.83%¥3.93B
301033SZMedprin
28.09x--¥3.44B
688358SHCHISON MEDICAL
25.75x17.31%¥2.98B
688314SHKontour Medical
28.25x--¥2.40B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.